A vs NRIX · P/E 29, rev $1.88B vs rev $54.5M
Agilent Technologies Inc (A) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
A currently screens at market cap $33.70B and trailing P/E 29.2. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the A and NRIX stock pages for the full models.
Not investment advice.